Close this search box.

American firm GenCanna acquires UK-based CBD Capital

US CBD leader GenCanna has announced its acquisition of the London-based producer CBD Capital as it continues to expand across global markets.

The Kentucky-based firm is an established producer of full-spectrum and broad-spectrum CBD and other cannabinoids for bulk supply and finished goods formulation.

The acquisition of CBD Capital enables GenCanna to broaden its bulk CBD product offering and distribution capabilities to its overseas customers.

It also plans to expand its formulation capabilities and B2B operations through CBD Capital’s network of valued partners.
CBD Capital also brings with it several sub-brands that will now enjoy accelerated product development and market expansion as more resources are devoted to them.

The addition of CBD Capital follows GenCanna’s acquisition of London-based CBD finished goods formulator and brand accelerator, Taylor Mammon, earlier this year.

Andrew Barnett, CEO of GenCanna commented: “The highly strategic acquisition of CBD Capital widens and solidifies GenCanna’s leadership position across high-growth CBD markets in the United Kingdom, the European Union, and the rest of the world.

“As a long-term partner of CBD Capital, we are deeply familiar with its impressive business, which will significantly boost GenCanna’s ability to provide our growing global customer base with deepened and broadened services — such as greater formulation capability and expanded finished goods versatility, increased supply chain flexibility, and quick-to-market turnaround.

Barnett added: “We look forward to leveraging CBD Capital’s strong industry experience and passion as we develop end-to-end, turnkey solutions that speed sales and maximise gross margin dollars for our customers. This is the GenCanna way.”

With CBD Capital’s recent opening of a new base in Rotterdam, Netherlands, which facilitates next-day distribution capabilities to markets throughout the European Union, the company is strategically and logistically positioned to further growth and market penetration.

CBD Capital CEO, Hassan Akhtar, will continue to serve in his current role.

“We are thrilled to join the growing family of GenCanna CBD companies,” said Akhtar.

“The injection of both financial and human capital, combined with GenCanna’s formidable CBD ingredient extraction and refinement sciences, and its sterling compliance track record, will now greatly facilitate the expansion and completion of several key channel strategies and market growth initiatives currently within the CBD Capital pipeline.”

[activecampaign form=31]


Related Posts

Related Posts


Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you


Browse by Tags




© 2023 Prohibition Holdings Ltd. All Rights Reserved.


Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?